Cleared Traditional

K942638 - SIMULTRAC LH/FSH RADIOUMMUNOASSAY KIT

K942638 is an FDA 510(k) clearance for SIMULTRAC LH/FSH RADIOUMMUNOASSAY KIT, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 1 Chemistry device with product code CEP cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K942638 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
96d
Days
Class 1
Risk

K942638 is an FDA 510(k) clearance for the SIMULTRAC LH/FSH RADIOUMMUNOASSAY KIT. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Orangeburg, US). The FDA issued a Cleared decision on September 7, 1994 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K942638

510(k) Number K942638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 1994
Decision Date September 07, 1994
Days to Decision 96 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 88d · This submission: 96d
Pathway characteristics
Predicate-based equivalence.

CEP Device Classification - Class 1, General Controls

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 101
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K942638.
CHEMILUMINESCENCE LH
K935319 · Nichols Institute Diagnostics · Apr 1995
PRO-STEP LH OVULATION PREDICTION TEST
K943252 · Disease Detection International, Inc. · Oct 1994
DUPONT ACA PLUS LUTEINIZING HORMONE (LH) METHOD
K943996 · Dupont Medical Products · Oct 1994
ACCESS(R) HUMAN LUTEINZING HORMONE ASSAY
K940549 · Bio-Rad Laboratories, Inc. · Apr 1994
VISTA(R) HUMAN LUTEINIZING HORMONE(HLH) ASSAY
K926394 · Syva Co. · May 1993
COBAS CORE LH EIA
K930306 · Roche Diagnostic Systems, Inc. · May 1993